Key Global Issue – Antimicrobial Resistance Infections

18 November 2019

Antimicrobial Resistance is the ability of microorganisms to resist to the action of one or more antimicrobial agents like ATB. Antimicrobial Resistance infections are increasing and these infections can affect anyone, of any age, in any country. 700,000 people die every year globally and 25,000 in Europe because of these resistances. Without action by 2050 someone could die every 3 seconds, likely killing more people than cancer. Rapid detection and rapid characterization are urgently needed to fight efficiently against MDR bacteria, administrate appropriate antimicrobial therapy and to prevent further spread.

How does antibiotic resistance occur?

When antibiotics are introduced in a bacterial population, most of the population dies but some resistant bacteria may survive. These resistant bacteria will continue to proliferate despite the presence of the antibiotic. In time, their population will increase until it becomes comprised mainly of resistant bacteria.

What causes antibiotic resistance?

  • Overprescribing of antibiotics
  • Patients not taking antibiotics as prescribed
  • Natural occurrence through adaption to the environment
  • Unnecessary antibiotics used in agriculture
  • Poor infection control in hospitals and clinics
  • Poor hygiene and sanitation practices
  • Lack of rapid laboratory tests

Detecting antimicrobial resistance

NG tests from NG Biotech developed in collaboration with the French CEA, are a new range of rapid tests for Antimicrobial Resistance detection from cultured colonies. These cutting edge tests enable rapid detection in just 15 minutes with results you can trust.

Why choose the NG Biotech rapid tests?

  • Superior accuracy: 100% sensitivity and specificity compared to molecular methods
  • Quality of raw materials developed by French CEA
  • Easy to use: no lab equipment required
  • Simple and rapid: results in 15 minutes
  • Low cost: Much less expensive than PCR

Click below for more information on the NG Biotech tests